卡倍亿 reported revenue of ¥2.23B for the period ended 2026-06-30, +22.1% year on year. Net income was ¥0.11B, a 4.9% net margin on a 9.6% gross margin. The largest revenue line is 普通线 at 84% of the total. Free cash flow for the period was ¥-0.22B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.23B | +22.1% |
| Gross profit | ¥0.21B | — |
| Operating income | ¥0.13B | — |
| Net income | ¥0.11B | +20.3% |
| Gross margin | 9.6% | Net margin 4.9% |
| Revenue Q/Q | +21.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 普通线 | ¥1.88B | 84.2% |
| 新能源线 | ¥0.28B | 12.3% |
| 其他(补充) | ¥0.06B | 2.7% |
| 数据线 | ¥0.01B | 0.6% |
| 高速铜缆 | ¥0.00B | 0.2% |
| 航天线束 | ¥0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.02B | 90.4% |
| R&D | ¥0.05B | 2.2% |
| SG&A | ¥0.05B | 2.4% |
| Tax & other | ¥0.02B | 0.8% |
| Item | Amount |
|---|---|
| Total assets | ¥5.03B |
| Total liabilities | ¥3.58B |
| Shareholders' equity | ¥1.45B |
| Equity / assets | 28.8% |
| Operating cash flow | ¥-0.10B |
| Capital expenditure | ¥0.12B |
| Free cash flow | ¥-0.22B |
| Cash conversion (OCF / net income) | -186% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
南大环境 ・ 大宏立 ・ 圣元环保 ・ 杰美特 ・ 康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies